Teva Pharmaceuticals USA recalls Risedronate Sodium Delayed-release Tablets, 35 mg, Once-a-Week, 1 tablet per blister (NDC 0093-5509-19), packaged in 4 b
Recalled January 25, 2017 · FDA recall D-0431-2017 · Teva Pharmaceuticals USA
Hazard
Failed Dissolution Specifications · FDA Class III
Units
6,800 cartons
Sold at
Nationwide in the USA and Puerto Rico
Description
Failed Dissolution Specifications
Product
Risedronate Sodium Delayed-release Tablets, 35 mg, Once-a-Week, 1 tablet per blister (NDC 0093-5509-19), packaged in 4 blisters per carton (NDC 0093-5509-44), Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454.
Manufacturer(s)
Teva Pharmaceuticals USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →